InsiderClue
Insiders · Profile

Matis Louis

SVP, Chief Development Officer at PALVELLA THERAPEUTICS. Filing since 13 Jun 2016. CIK 0001650991

Company
Date
Role
Action
Shares
Amount
Of holding
PVLA PALVELLA THERAPEUTICS, INC.
14 Jun 2016
SVP, Chief Development Officer
Bought
7,915
$13.53K
380%
PVLA PALVELLA THERAPEUTICS, INC.
13 Jun 2016
SVP, Chief Development Officer
Bought
2,085
$3.50K
opened
2 decisions on file.